MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2
Authors
Keywords
Ovarian cancer, MiR-25, Proliferation, Migration, Invasion
Journal
TUMOR BIOLOGY
Volume 35, Issue 12, Pages 12339-12344
Publisher
Springer Nature
Online
2014-09-01
DOI
10.1007/s13277-014-2546-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Implications for High Expression of MiR-25 in Lung Adenocarcinomas of Female Non-smokers
- (2014) Fang-Xiu Xu et al. Asian Pacific Journal of Cancer Prevention
- MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2
- (2014) Ying Xia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-25 expression level is an independent prognostic factor in epithelial ovarian cancer
- (2014) X. Wang et al. Clinical & Translational Oncology
- MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2
- (2014) Weiping Li et al. FEBS LETTERS
- The role of miR-148a in gastric cancer
- (2014) Jiazeng Xia et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Noncoding RNAs in Endocrine Malignancy
- (2014) J. Kentwell et al. ONCOLOGIST
- MiR-26a Promotes Ovarian Cancer Proliferation and Tumorigenesis
- (2014) Wenjing Shen et al. PLoS One
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evidence for a Tumor Suppressor Role for the Large Tumor Suppressor Genes LATS1 and LATS2 in Human Cancer
- (2013) Tian Yu et al. GENETICS
- Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis
- (2013) Xiaoming Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Major clinical research advances in gynecologic cancer in 2012
- (2013) Dong Hoon Suh et al. Journal of Gynecologic Oncology
- Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer
- (2013) Shaosheng Wang et al. MEDICAL ONCOLOGY
- miR-25 promotes gastric cancer cells growth and motility by targeting RECK
- (2013) Hongying Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases
- (2013) J. J. Adler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour angiogenesis regulation by the miR-200 family
- (2013) Chad V. Pecot et al. Nature Communications
- MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma
- (2012) Xiaohui Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-93 enhances angiogenesis and metastasis by targeting LATS2
- (2012) Ling Fang et al. CELL CYCLE
- LATS tumor suppressor: A new governor of cellular homeostasis
- (2010) Stacy Visser et al. CELL CYCLE
- Current status of gynecological cancer in China
- (2009) Kidong Kim et al. Journal of Gynecologic Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started